Retinal Gene Therapy Gets $420 Million Boost

Kilder

• Nature: TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD - Nature
• Nature: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial - Nature
• Nature: Powerful new antibiotic that can kill superbugs discovered in soil bacteria - Nature
• Nature: IL-12-releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer - Nature
• Fiercebiotech: 4DMT eyes $420M deal from Otsuka, with cash aimed at retinal gene therapy's phase 3 plans - Fierce Biotech
• Bioworld: UK researchers developing glucose-powered bioelectronics - BioWorld MedTech

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.